Relationship between body fat mass, carbohydrate tolerance and IRI response during glucose infusion in subjects with early diabetes.
We have studied the interrelationship of total body fat mass, carbohydrate tolerance and IRI response in 17 non-obese and obese subjects, who were suspected of having early diabetes. We carried out an i.v. glucose infusion test consisting of a priming injection of 0.33 g/kg followed by constant glucose infusion of 12 mg/kg/min in all persons. Total body fat mass was estimated by the tritium dilution method. There was a positive correlation of body fat mass, fasting glucose concentration and blood glucose concentration at 150 min as well as a strong correlation between body fat mass and BG area 60--120 min as parameters of carbohydrate tolerance in all subjects, i.e. the degree of carbohyrate intolerance was directly related to the quantity of total body fat mass. A similar correlation was found when the non-obese and obese groups were analyzed separately. In neither group did total body fat mass correlate with parameters of IRI response. In obese subjects with pathological carbohydrate tolerance, however, a positive correlation of basal IRI concentration and total body fat mass was found. Furthermore, a close relation between basal IRI level and parameters of carbohydrate tolerance could be demonstrated in obese subjects. The present study failed to demonstrate any correlation of parameters of carbohydrate tolerance and glucose-induced IRI response in either group. Thus, the significant relationship between body fat mass and degree of carbohydrate intolerance indicates that body fat mass plays an important role in the disturbance of blood glucose homeostasis in early diabetes with and without obesity.
D000273:Adipose Tissue / Q000378:metabolism; D000941:Antigens / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D002239:Carbohydrate Metabolism, Inborn Errors / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D009765:Obesity / Q000378:metabolism*; D010179:Pancreas / Q000378:metabolism*
D000941:Antigens; D001786:Blood Glucose; D007328:Insulin